Mednax Company Profile (NYSE:MD)

About Mednax (NYSE:MD)

Mednax logoMEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of December 31, 2016, the Company's national network consisted of over 3,600 affiliated physicians, including over 1,130 physicians providing neonatal clinical care, in 35 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. As of December 31, 2016, the Company had over 1,390 affiliated physicians providing anesthesia care to patients in connection with surgical and other procedures, as well as pain management. As of December 31, 2016, the Company had 270 affiliated physicians providing maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Facilities & Services - NEC
  • Sub-Industry: Health Care Services
  • Symbol: NYSE:MD
  • CUSIP: 58502B10
  • Web: www.mednax.com
Capitalization:
  • Market Cap: $5.37 billion
  • Outstanding Shares: 93,016,000
Average Prices:
  • 50 Day Moving Avg: $57.74
  • 200 Day Moving Avg: $63.76
  • 52 Week Range: $53.80 - $76.04
P/E:
  • Trailing P/E Ratio: 17.34
  • Foreward P/E Ratio: 14.67
  • P/E Growth: 1.12
Sales & Book Value:
  • Annual Revenue: $3.27 billion
  • Price / Sales: 1.65
  • Book Value: $29.91 per share
  • Price / Book: 1.94
Profitability:
  • EBIDTA: $648.78 million
  • Net Margins: 9.54%
  • Return on Equity: 12.81%
  • Return on Assets: 6.60%
Debt:
  • Debt-to-Equity Ratio: 0.68%
  • Current Ratio: 1.71%
  • Quick Ratio: 1.71%
Misc:
  • Average Volume: 924,517 shs.
  • Beta: 0.44
  • Short Ratio: 8.38
 
Frequently Asked Questions for Mednax (NYSE:MD)

What is Mednax's stock symbol?

Mednax trades on the New York Stock Exchange (NYSE) under the ticker symbol "MD."

How were Mednax's earnings last quarter?

Mednax, Inc (NYSE:MD) announced its quarterly earnings data on Thursday, May, 4th. The company reported $0.75 EPS for the quarter, topping the Zacks' consensus estimate of $0.74 by $0.01. The company earned $835.60 million during the quarter, compared to the consensus estimate of $837.01 million. Mednax had a return on equity of 12.81% and a net margin of 9.54%. The company's quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter last year, the company earned $0.87 EPS. View Mednax's Earnings History.

What guidance has Mednax issued on next quarter's earnings?

Mednax updated its second quarter earnings guidance on Thursday, May, 4th. The company provided earnings per share (EPS) guidance of $0.85-0.89 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.00.

Where is Mednax's stock going? Where will Mednax's stock price be in 2017?

10 brokerages have issued 12 month price objectives for Mednax's stock. Their forecasts range from $53.00 to $72.00. On average, they expect Mednax's share price to reach $64.50 in the next twelve months. View Analyst Ratings for Mednax.

What are analysts saying about Mednax stock?

Here are some recent quotes from research analysts about Mednax stock:

  • 1. According to Zacks Investment Research, "Mednax, Inc., formerly Pediatrix Medical Group, Inc. is a healthcare services company that focuses on physician services for newborn, maternal-fetal, pediatric subspecialty and anesthesia care. The company ,through its subsidiaries, provides these services in the United States and Puerto Rico. In addition, MEDNAX engages in clinical research, monitoring clinical outcomes, and implementing clinical initiatives. " (4/27/2017)
  • 2. Jefferies Group LLC analysts commented, "Following MD's 5% EPS miss in Q4, we believe our Hold thesis from our December downgrade still holds and would expect the stock to give up some of its premium valuation pending improved earnings visibility. Broader birth trends remain subdued, MD faces its toughest comp of the year in Q1-17, and the company's deal flow remains relatively moderate, leading us to believe that the achievability of Q1 guidance (following 3 consecutive EPS misses) remains uncertain." (2/8/2017)

Who are some of Mednax's key competitors?

Who are Mednax's key executives?

Mednax's management team includes the folowing people:

  • Cesar L. Alvarez, Chairman of the Board
  • Joseph M. Calabro, President, Chief Operating Officer
  • Roger J. Medel M.D., Chief Executive Officer, Director
  • Vivian Lopez-Blanco, Chief Financial Officer, Treasurer
  • David A. Clark, President - MEDNAX National Medical Group Division
  • John C. Pepia, Senior Vice President, Chief Accounting Officer
  • Dominic J. Andreano, Senior Vice President, General Counsel, Secretary
  • Manuel Kadre, Lead Independent Director
  • Karey D. Barker, Independent Director
  • Waldemar A. Carlo M.D., Independent Director

Who owns Mednax stock?

Mednax's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Riverbridge Partners LLC (0.96%), Fenimore Asset Management Inc. (0.94%), Hermes Investment Management Ltd. (0.68%), Handelsbanken Fonder AB (0.22%), BB&T Corp (0.16%) and BTIM Corp. (0.10%). Company insiders that own Mednax stock include Cesar L Alvarez, Dominic J Andreano, Enrique Sosa, John C Pepia, Joseph M Calabro, Karl B Wagner, Manuel Kadre, Md Carlo A Waldemar, Md Pascal J Goldschmidt, Michael D Stanley, Paul G Gabos, Roger Md Medel and Vivian Lopez-Blanco. View Institutional Ownership Trends for Mednax.

Who sold Mednax stock? Who is selling Mednax stock?

Mednax's stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Hermes Investment Management Ltd., Handelsbanken Fonder AB, APG Asset Management N.V., Riverbridge Partners LLC, US Bancorp DE, Profit Investment Management LLC and Aperio Group LLC. Company insiders that have sold Mednax stock in the last year include Dominic J Andreano, Enrique Sosa, John C Pepia, Joseph M Calabro, Md Carlo A Waldemar, Md Pascal J Goldschmidt, Paul G Gabos and Vivian Lopez-Blanco. View Insider Buying and Selling for Mednax.

Who bought Mednax stock? Who is buying Mednax stock?

Mednax's stock was purchased by a variety of institutional investors in the last quarter, including Handelsinvest Investeringsforvaltning, Fenimore Asset Management Inc., Mn Services Vermogensbeheer B.V., BB&T Corp, First Citizens Bank & Trust Co., BTIM Corp., NN Investment Partners Holdings N.V. and Oregon Public Employees Retirement Fund. Company insiders that have bought Mednax stock in the last two years include Manuel Kadre and Md Pascal J Goldschmidt. View Insider Buying and Selling for Mednax.

How do I buy Mednax stock?

Shares of Mednax can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Mednax's stock price today?

One share of Mednax stock can currently be purchased for approximately $58.10.


MarketBeat Community Rating for Mednax (NYSE MD)
Community Ranking:  2.3 out of 5 ( )
Outperform Votes:  200 (Vote Outperform)
Underperform Votes:  237 (Vote Underperform)
Total Votes:  437
MarketBeat's community ratings are surveys of what our community members think about Mednax and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Mednax (NYSE:MD) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 8 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $64.50 (11.02% upside)

Analysts' Ratings History for Mednax (NYSE:MD)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/6/2017Jefferies Group LLCReiterated RatingHold$50.00 -> $53.00MediumView Rating Details
6/22/2017StephensUpgradeEqual Weight -> Overweight$55.00 -> $68.00HighView Rating Details
5/30/2017MizuhoLower Price TargetNeutral -> Neutral$64.00 -> $58.00LowView Rating Details
5/25/2017Stifel NicolausLower Price TargetHold$65.00 -> $58.00LowView Rating Details
5/4/2017Bank of America CorporationDowngradeBuy -> UnderperformLowView Rating Details
3/21/2017Robert W. BairdDowngradeOutperform -> Neutral$72.00HighView Rating Details
3/10/2017J P Morgan Chase & CoReiterated RatingOverweight -> Neutral$69.00LowView Rating Details
12/9/2016Goldman Sachs Group, Inc. (The)Initiated CoverageNeutral$66.00N/AView Rating Details
10/27/2016Raymond James Financial, Inc.DowngradeOutperform -> Market PerformN/AView Rating Details
8/17/2016Citigroup Inc.Lower Price TargetNeutral$76.00 -> $72.00N/AView Rating Details
3/14/2016Piper Jaffray CompaniesReiterated RatingOverweight$76.00N/AView Rating Details
3/7/2016Susquehanna Bancshares IncDowngradePositive -> Neutral$94.00 -> $70.00N/AView Rating Details
9/20/2015William BlairReiterated RatingBuyN/AView Rating Details
7/31/2015Dougherty & CoBoost Price TargetBuy$88.00 -> $90.00N/AView Rating Details
(Data available from 7/24/2015 forward)

Earnings

Earnings History for Mednax (NYSE:MD)
Earnings by Quarter for Mednax (NYSE:MD)
Earnings History by Quarter for Mednax (NYSE MD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/4/2017Q1 2017$0.74$0.75$837.01 million$835.60 millionViewN/AView Earnings Details
2/7/2017Q416$1.06$1.00$842.15 million$831.00 millionViewListenView Earnings Details
10/27/2016Q316$1.05$1.09$821.18 million$828.00 millionViewListenView Earnings Details
7/28/2016Q216$1.07$1.03$775.68 million$772.00 millionViewListenView Earnings Details
4/28/2016Q116$0.86$0.87$741.49 million$752.60 millionViewListenView Earnings Details
2/4/2016Q415$1.10$1.13$748.02 million$742.00 millionViewListenView Earnings Details
10/29/2015Q315$0.97$1.10$730.63 million$722.30 millionViewListenView Earnings Details
7/30/2015Q215$0.88$0.97$677.02 million$676.60 millionViewListenView Earnings Details
4/30/2015Q115$0.71$0.72$641.24 million$639.40 millionViewListenView Earnings Details
1/29/2015Q414$0.87$0.89$637.90 million$651.00 millionViewListenView Earnings Details
10/30/2014Q314$0.85$0.86$619.61 million$627.00 millionViewListenView Earnings Details
7/31/2014Q214$0.78$0.79$603.00 million$595.54 millionViewListenView Earnings Details
5/1/2014Q114$0.63$0.63$574.80 million$566.00 millionViewListenView Earnings Details
1/30/2014Q4$0.75$0.20$555.30 million$567.00 millionViewListenView Earnings Details
10/31/2013Q313$1.48$1.52$556.63 million$555.00 millionViewListenView Earnings Details
7/30/2013Q2 2013$1.36$1.37$533.39 million$529.18 millionViewListenView Earnings Details
5/2/2013Q1 2013$1.09$1.10$504.24 million$502.70 millionViewListenView Earnings Details
1/31/2013Q4 2012$1.30$1.32$473.70 million$471.30 millionViewListenView Earnings Details
11/1/2012Q312$1.28$1.32$470.60 million$473.10 millionViewN/AView Earnings Details
7/31/2012$1.19$1.22ViewN/AView Earnings Details
5/3/2012$1.00$0.98ViewN/AView Earnings Details
2/2/2012$1.19$1.19ViewN/AView Earnings Details
11/1/2011$1.18$1.19ViewN/AView Earnings Details
8/2/2011$1.15$1.15ViewN/AView Earnings Details
5/3/2011$0.91$0.94ViewN/AView Earnings Details
2/3/2011$1.12$1.12ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Mednax (NYSE:MD)
2017 EPS Consensus Estimate: $3.86
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.80$0.81$0.81
Q2 20172$0.99$1.00$1.00
Q3 20173$0.90$1.09$1.02
Q4 20173$0.94$1.09$1.03
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Mednax (NYSE:MD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Mednax (NYSE:MD)
Insider Ownership Percentage: 2.40%
Insider Trades by Quarter for Mednax (NYSE:MD)
Institutional Ownership by Quarter for Mednax (NYSE:MD)
Insider Trades by Quarter for Mednax (NYSE:MD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/14/2017Md Pascal J GoldschmidtDirectorSell1,969$57.57$113,355.33View SEC Filing  
6/1/2017Joseph M CalabroInsiderSell23,327$55.00$1,282,985.00View SEC Filing  
5/5/2017Manuel KadreDirectorBuy21,704$55.79$1,210,866.16View SEC Filing  
5/5/2017Vivian Lopez-BlancoCFOSell7,778$55.82$434,167.96View SEC Filing  
2/23/2017Enrique SosaDirectorSell10,668$69.65$743,026.20View SEC Filing  
2/17/2017Vivian Lopez-BlancoCFOSell15,164$70.01$1,061,631.64View SEC Filing  
2/16/2017Dominic J AndreanoSVPSell6,000$69.59$417,540.00View SEC Filing  
2/16/2017John C PepiaInsiderSell2,500$69.58$173,950.00View SEC Filing  
2/16/2017Paul G GabosDirectorSell21,336$69.63$1,485,625.68View SEC Filing  
2/10/2017Md Pascal J GoldschmidtDirectorSell25,294$67.82$1,715,439.08View SEC Filing  
2/9/2017Md Carlo A WaldemarDirectorSell5,334$67.90$362,178.60View SEC Filing  
1/17/2017Vivian Lopez-BlancoCFOSell10,000$70.95$709,500.00View SEC Filing  
12/7/2016Md Pascal J GoldschmidtDirectorBuy2,100$66.52$139,692.00View SEC Filing  
9/14/2016Md Pascal J GoldschmidtDirectorSell1,500$65.01$97,515.00View SEC Filing  
6/13/2016Dominic J AndreanoSVPSell3,922$68.80$269,833.60View SEC Filing  
6/8/2016Md Carlo A WaldemarDirectorSell5,334$70.50$376,047.00View SEC Filing  
6/7/2016Karl B WagnerInsiderSell27,482$68.45$1,881,142.90View SEC Filing  
6/1/2016Joseph M CalabroCOOSell28,347$67.78$1,921,359.66View SEC Filing  
6/1/2016Michael D StanleyInsiderSell14,778$67.78$1,001,652.84View SEC Filing  
5/16/2016Dominic J AndreanoSVPSell3,000$68.53$205,590.00View SEC Filing  
5/2/2016Vivian Lopez-BlancoCFOSell9,350$71.22$665,907.00View SEC Filing  
3/11/2016Md Pascal J GoldschmidtDirectorSell3,100$65.00$201,500.00View SEC Filing  
2/29/2016Paul G GabosDirectorSell10,668$67.15$716,356.20View SEC Filing  
12/11/2015Md Pascal J. GoldschmidtDirectorSell5,250$70.99$372,697.50View SEC Filing  
9/8/2015Cesar L. AlvarezDirectorSell10,668$81.00$864,108.00View SEC Filing  
8/27/2015Roger Md MedelCEOSell100,000$80.27$8,027,000.00View SEC Filing  
6/8/2015Karl B WagnerInsiderSell37,820$70.28$2,657,989.60View SEC Filing  
6/3/2015Joseph M CalabroCOOSell108,071$70.51$7,620,086.21View SEC Filing  
3/9/2015Md Pascal J GoldschmidtDirectorSell8,500$71.25$605,625.00View SEC Filing  
2/26/2015Roger Md MedelCEOSell100,000$71.61$7,161,000.00View SEC Filing  
2/20/2015Md Carlo A WaldemarDirectorSell10,668$71.50$762,762.00View SEC Filing  
2/6/2015Dominic J AndreanoSVPSell3,200$70.75$226,400.00View SEC Filing  
2/6/2015Vivian Lopez-BlancoCFOSell8,250$69.95$577,087.50View SEC Filing  
2/2/2015Paul G GabosDirectorSell17,584$68.07$1,196,942.88View SEC Filing  
1/30/2015William C HawkCOOSell3,598$68.50$246,463.00View SEC Filing  
11/14/2014Roger Md MedelCEOSell51,290$62.59$3,210,241.10View SEC Filing  
11/13/2014Roger Md MedelCEOSell63,440$62.55$3,968,172.00View SEC Filing  
11/7/2014Roger Md MedelCEOSell128,833$62.60$8,064,945.80View SEC Filing  
11/5/2014Roger Md MedelCEOSell169,845$62.60$10,632,297.00View SEC Filing  
11/4/2014Roger Md MedelCEOSell15,052$62.52$941,051.04View SEC Filing  
11/3/2014Roger Md MedelCEOSell10,881$62.52$680,280.12View SEC Filing  
10/31/2014Roger Md MedelCEOSell61,592$62.58$3,854,427.36View SEC Filing  
10/30/2014Karl B WagnerInsiderSell40,000$62.50$2,500,000.00View SEC Filing  
10/30/2014Vivian Lopez-BlancoCFOSell8,800$60.00$528,000.00View SEC Filing  
7/30/2014Karl B WagnerInsiderSell80,000$60.00$4,800,000.00View SEC Filing  
6/10/2014Dominic J AndreanoSVPSell2,252$58.48$131,696.96View SEC Filing  
6/6/2014Karl B WagnerInsiderSell44,596$58.53$2,610,203.88View SEC Filing  
6/5/2014William C HawkCOOSell6,911$57.66$398,488.26View SEC Filing  
6/2/2014David A ClarkCOOSell16,230$57.00$925,110.00View SEC Filing  
6/2/2014Michael D StanleyInsiderSell18,006$57.00$1,026,342.00View SEC Filing  
5/9/2014Karl WagnerInsiderSell79,524$57.09$4,540,025.16View SEC Filing  
5/9/2014Md Pascal GoldschmidtDirectorSell30,000$57.11$1,713,300.00View SEC Filing  
5/8/2014Joseph CalabroCOOSell137,500$57.06$7,845,750.00View SEC Filing  
2/20/2014Dominic AndreanoSVPSell3,000$61.00$183,000.00View SEC Filing  
2/10/2014Joseph CalabroCOOSell150,000$55.55$8,332,500.00View SEC Filing  
2/10/2014Md Carlo WaldemarDirectorSell10,668$55.40$591,007.20View SEC Filing  
11/7/2013Enrique SosaDirectorSell5,334$107.00$570,738.00View SEC Filing  
11/7/2013Karl WagnerInsiderSell1,800$107.60$193,680.00View SEC Filing  
9/11/2013William C HawkCOOSell3,162$100.62$318,160.44View SEC Filing  
9/10/2013Dominic J AndreanoSVPSell3,718$99.63$370,424.34View SEC Filing  
8/7/2013Karl WagnerInsiderSell25,000$98.01$2,450,250.00View SEC Filing  
8/2/2013Joseph M CalabroCOOSell36,154$98.57$3,563,699.78View SEC Filing  
6/3/2013David A ClarkCOOSell8,645$91.01$786,781.45View SEC Filing  
6/3/2013Michael D StanleyInsiderSell8,906$91.01$810,535.06View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Mednax (NYSE:MD)
Latest Headlines for Mednax (NYSE:MD)
Source:
DateHeadline
finance.yahoo.com logoETFs with exposure to MEDNAX, Inc. : July 24, 2017
finance.yahoo.com - July 24 at 6:28 PM
americanbankingnews.com logo$851.11 Million in Sales Expected for Mednax, Inc (NYSE:MD) This Quarter
www.americanbankingnews.com - July 21 at 7:35 PM
finance.yahoo.com logoMEDNAX, Inc. breached its 50 day moving average in a Bearish Manner : MD-US : July 20, 2017
finance.yahoo.com - July 21 at 2:10 AM
finance.yahoo.com logoMEDNAX 2017 Second Quarter Conference Call/Webcast Scheduled for Friday, July 28, 2017
finance.yahoo.com - July 18 at 11:14 PM
americanbankingnews.com logoMednax, Inc (MD) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - July 17 at 2:50 PM
finance.yahoo.com logoETFs with exposure to MEDNAX, Inc. : July 14, 2017
finance.yahoo.com - July 15 at 6:21 AM
finance.yahoo.com logoMEDNAX Radiology and vRad to Exhibit at AHRA 2017 Annual Meeting
finance.yahoo.com - July 11 at 1:27 AM
americanbankingnews.com logoMednax, Inc (NYSE:MD) Given "Hold" Rating at Jefferies Group LLC
www.americanbankingnews.com - July 9 at 7:22 AM
americanbankingnews.com logoQ3 2017 Earnings Forecast for Mednax, Inc (NYSE:MD) Issued By Jefferies Group
www.americanbankingnews.com - July 7 at 10:53 AM
finance.yahoo.com logoETFs with exposure to MEDNAX, Inc. : July 4, 2017
finance.yahoo.com - July 4 at 6:43 PM
americanbankingnews.com logo Analysts Anticipate Mednax, Inc (MD) Will Post Quarterly Sales of $850.54 Million
www.americanbankingnews.com - June 25 at 1:02 PM
americanbankingnews.com logoMednax, Inc (MD) Upgraded to Overweight at Stephens
www.americanbankingnews.com - June 25 at 7:11 AM
americanbankingnews.com logoMednax, Inc (MD) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - June 23 at 7:38 PM
americanbankingnews.com logoZacks: Analysts Expect Mednax, Inc (MD) to Announce $0.81 Earnings Per Share
www.americanbankingnews.com - June 23 at 11:32 AM
nasdaq.com logoMednax, Inc. Reaches Analyst Target Price
www.nasdaq.com - June 22 at 8:44 AM
finance.yahoo.com logoMEDNAX, Inc. breached its 50 day moving average in a Bullish Manner : MD-US : June 22, 2017
finance.yahoo.com - June 22 at 8:44 AM
finance.yahoo.com logoMEDNAX Announces Acquisition of Maternal-Fetal Medicine Practice in Tennessee
finance.yahoo.com - June 20 at 7:28 PM
americanbankingnews.com logoMEDNAX Inc (MD) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - June 20 at 3:04 PM
finance.yahoo.com logoETFs with exposure to MEDNAX, Inc. : June 19, 2017
finance.yahoo.com - June 19 at 5:32 PM
finance.yahoo.com logoMEDNAX, Inc. :MD-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017
finance.yahoo.com - June 16 at 7:24 PM
finance.yahoo.com logoSnap Has Shed an Astounding $13 Billion in Value and Now the Stock Is Trading Near Its IPO Price
finance.yahoo.com - June 16 at 7:40 AM
seekingalpha.com logoMEDNAX (MD) Presents At The William Blair 2017 Growth Stock Conference - Slideshow
seekingalpha.com - June 14 at 9:47 PM
americanbankingnews.com logoMednax, Inc (MD) Director Md Pascal J. Goldschmidt Sells 1,969 Shares
www.americanbankingnews.com - June 14 at 8:19 PM
benzinga.com logo4 Reasons to Stay Away from Mednax Now
www.benzinga.com - June 8 at 10:27 AM
finance.yahoo.com logo4 Reasons to Stay Away from Mednax (MD) Now
finance.yahoo.com - June 7 at 6:06 PM
americanbankingnews.com logoAMN Healthcare Services (AMN) and MEDNAX (MD) Head-To-Head Survey
www.americanbankingnews.com - June 6 at 8:44 AM
americanbankingnews.com logoMEDNAX Inc (MD) Lowered to Hold at ValuEngine
www.americanbankingnews.com - June 4 at 8:06 AM
finance.yahoo.com logoA Deep Analysis of 6 Five-Star Companies
finance.yahoo.com - June 3 at 8:09 AM
americanbankingnews.com logoMEDNAX Inc (MD) Insider Joseph M. Calabro Sells 23,327 Shares
www.americanbankingnews.com - June 2 at 7:42 PM
finance.yahoo.com logoWhat Makes MEDNAX (MD) a Strong Sell?
finance.yahoo.com - May 31 at 6:51 PM
americanbankingnews.com logoMEDNAX Inc (MD) Expected to Post Quarterly Sales of $850.54 Million
www.americanbankingnews.com - May 31 at 11:10 AM
americanbankingnews.com logoMEDNAX Inc (MD) PT Lowered to $58.00
www.americanbankingnews.com - May 30 at 7:24 AM
americanbankingnews.com logoMEDNAX Inc (MD) Expected to Announce Earnings of $0.81 Per Share
www.americanbankingnews.com - May 29 at 10:26 PM
nasdaq.com logoOversold Conditions For Mednax (MD)
www.nasdaq.com - May 26 at 7:16 PM
americanbankingnews.com logoMEDNAX Inc (MD) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - May 26 at 2:52 PM
americanbankingnews.com logoMEDNAX Inc (MD) Price Target Cut to $58.00 by Analysts at Stifel Nicolaus
www.americanbankingnews.com - May 25 at 10:41 AM
americanbankingnews.com logoMEDNAX Inc (MD) Downgraded to "C+" at TheStreet
www.americanbankingnews.com - May 19 at 1:38 PM
americanbankingnews.com logoShort Interest in MEDNAX Inc (MD) Drops By 24.9%
www.americanbankingnews.com - May 16 at 7:14 AM
americanbankingnews.com logoInsider Selling: MEDNAX Inc (MD) CFO Sells 7,778 Shares of Stock
www.americanbankingnews.com - May 8 at 7:36 PM
americanbankingnews.com logoMEDNAX Inc (MD) Director Buys $1,210,866.16 in Stock
www.americanbankingnews.com - May 8 at 7:17 PM
americanbankingnews.com logoMEDNAX Inc (MD) Expected to Post Quarterly Sales of $859.84 Million
www.americanbankingnews.com - May 6 at 9:53 AM
americanbankingnews.com logoMEDNAX (MD) Receives Daily Media Sentiment Score of 0.07
www.americanbankingnews.com - May 5 at 11:45 PM
finance.yahoo.com logoEdited Transcript of MD earnings conference call or presentation 4-May-17 2:00pm GMT
finance.yahoo.com - May 4 at 11:34 PM
americanbankingnews.com logoMEDNAX Inc (MD) Rating Lowered to Underperform at Bank of America Corp
www.americanbankingnews.com - May 4 at 10:56 PM
americanbankingnews.com logoMEDNAX Inc (MD) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS
www.americanbankingnews.com - May 4 at 9:48 PM
americanbankingnews.com logoMEDNAX Inc (MD) Issues Q2 Earnings Guidance
www.americanbankingnews.com - May 4 at 12:04 PM
finance.yahoo.com logoMEDNAX Reports First Quarter GAAP EPS of $0.59; Adjusted EPS of $0.75
finance.yahoo.com - May 4 at 11:45 AM
americanbankingnews.com logoMEDNAX Inc (MD) Expected to Post Earnings of $0.99 Per Share
www.americanbankingnews.com - May 4 at 7:46 AM
seekingalpha.com logoMednax misses by $0.13, misses on revenue
seekingalpha.com - May 4 at 6:07 AM
bizjournals.com logoSpecialized Health Services Stocks on Investors' Radar -- DaVita, Acadia Healthcare, HealthSouth, and MEDNAX
www.bizjournals.com - May 3 at 5:33 PM

Social

Chart

Mednax (MD) Chart for Monday, July, 24, 2017

This page was last updated on 7/24/2017 by MarketBeat.com Staff